Literature DB >> 14644011

Plasticity in serotonin control mechanisms in the gut.

Michael D Gershon1.   

Abstract

5-hydroxytryptamine (5-HT or serotonin) is a charged molecule and must be transported across biological membranes. Enzymes that catabolize 5-HT are all intracellular; therefore, 5-HT inactivation requires a high affinity transporter, known as serotonin transporter (SERT or 5-HTT). In the central and enteric nervous systems, SERT is located in serotonergic neurons; however, these neurons are not present in the gastrointestinal mucosa, where 5-HT initiates peristaltic and secretory reflexes. Instead, SERT is expressed by enterocytes. The severity of gastrointestinal effects caused by drugs that inhibit SERT, such as tricyclic antidepressants, selective serotonin reuptake inhibitors and cocaine, does not usually prevent their therapeutic or recreational use because backup transporters and alterations in receptor gene expression allow the gut to adapt, albeit imperfectly, to their toxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14644011     DOI: 10.1016/j.coph.2003.07.005

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  36 in total

Review 1.  Pharmacology of serotonin: what a clinician should know.

Authors:  F De Ponti
Journal:  Gut       Date:  2004-10       Impact factor: 23.059

Review 2.  Developmental biology of the enteric nervous system: pathogenesis of Hirschsprung's disease and other congenital dysmotilities.

Authors:  Michael D Gershon; Elyanne M Ratcliffe
Journal:  Semin Pediatr Surg       Date:  2004-11       Impact factor: 2.754

3.  TRPA1 agonists delay gastric emptying in rats through serotonergic pathways.

Authors:  Hitoshi Doihara; Katsura Nozawa; Eri Kawabata-Shoda; Ryosuke Kojima; Toshihide Yokoyama; Hiroyuki Ito
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-07-24       Impact factor: 3.000

4.  Effect of cerium oxide nanoparticles on intestinal serotonin in zebrafish.

Authors:  Rıfat Emrah Ozel; Akhtar Hayat; Kenneth N Wallace; Silvana Andreescu
Journal:  RSC Adv       Date:  2013-09-21       Impact factor: 3.361

Review 5.  Ontogeny and regulation of the serotonin transporter: providing insights into human disorders.

Authors:  Lynette C Daws; Georgianna G Gould
Journal:  Pharmacol Ther       Date:  2011-04-05       Impact factor: 12.310

6.  Endocrine cells in the ileum of patients with irritable bowel syndrome.

Authors:  Magdy El-Salhy; Odd Helge Gilja; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

7.  TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells.

Authors:  Katsura Nozawa; Eri Kawabata-Shoda; Hitoshi Doihara; Ryosuke Kojima; Hidetsugu Okada; Shinobu Mochizuki; Yorikata Sano; Kohei Inamura; Hitoshi Matsushime; Tomonobu Koizumi; Toshihide Yokoyama; Hiroyuki Ito
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-11       Impact factor: 11.205

Review 8.  Is irritable bowel syndrome an organic disorder?

Authors:  Magdy El-Salhy; Doris Gundersen; Odd Helge Gilja; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

9.  High densities of serotonin and peptide YY cells in the colon of patients with lymphocytic colitis.

Authors:  Magdy El-Salhy; Doris Gundersen; Jan Gunnar Hatlebakk; Trygve Hausken
Journal:  World J Gastroenterol       Date:  2012-11-14       Impact factor: 5.742

10.  Loss of ascl1a prevents secretory cell differentiation within the zebrafish intestinal epithelium resulting in a loss of distal intestinal motility.

Authors:  Gillian Roach; Rachel Heath Wallace; Amy Cameron; Rifat Emrah Ozel; Cintia F Hongay; Reshica Baral; Silvana Andreescu; Kenneth N Wallace
Journal:  Dev Biol       Date:  2013-01-23       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.